We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.2B
AUM Growth
+$540M
(+0.81%)
Cap. Flow
-$425M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
780
New
63
Increased
245
Reduced
379
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$840M |
| 2 |
RTX Corp
RTX
|
+$638M |
| 3 |
Trane Technologies
TT
|
+$326M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$299M |
| 5 |
Gilead Sciences
GILD
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$489M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$397M |
| 3 |
ExxonMobil
XOM
|
+$325M |
| 4 |
Comcast
CMCSA
|
+$322M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$293M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.95% |
| 2 | Healthcare | 16.68% |
| 3 | Technology | 16.63% |
| 4 | Industrials | 11.79% |
| 5 | Consumer Discretionary | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Sensient Technologies
SXT
$5.75B
| $8.82M | 0.01% |
128,012
-4,349
| -3% | -$271K |
|
427
Fresenius Medical Care
FMS
$12.3B
| $8.81M | 0.01% |
212,515
-13,000
| -6% | -$502K |
|
|
FUR
428
DELISTED
WINTHROP REALTY TRUST SHS BENE INT (NEW)
FUR
| $8.81M | 0.01% |
539,700
+53,050
| +11% | +$852K |
|
429
US Physical Therapy
USPH
$1.17B
| $8.77M | 0.01% |
184,617
-17,887
| -9% | -$760K |
|
430
Navigator Holdings
NVGS
$1.36B
| $8.65M | 0.01% |
453,090
+155,470
| +52% | +$2.81M |
|
|
MJN
431
DELISTED
Mead Johnson Nutrition Company
MJN
| $8.6M | 0.01% |
85,500
+500
| +0.6% | +$50.4K |
|
|
QTS
432
DELISTED
QTS REALTY TRUST, INC.
QTS
| $8.51M | 0.01% |
233,583
-6,117
| -3% | -$226K |
|
433
Credicorp
BAP
$29.3B
| $8.44M | 0.01% |
60,000
+5,000
| +9% | +$735K |
|
434
Hasbro
HAS
$13.3B
| $8.39M | 0.01% |
132,700
-100
| -0.1% | -$5.87K |
|
|
CVG
435
DELISTED
Convergys
CVG
| $8.36M | 0.01% |
+365,310
| New | +$7.72M |
|
|
CSGS
436
DELISTED
CSG Systems International
CSGS
| $8.22M | 0.01% |
270,613
-115,561
| -30% | -$3.25M |
|
|
XCRA
437
DELISTED
Xcerra Corporation
XCRA
| $8.18M | 0.01% |
920,228
+232,518
| +34% | +$2M |
|
|
ANH
438
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $8.16M | 0.01% |
1,603,710
-76,202
| -5% | -$396K |
|
|
PNY
439
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
| $8.15M | 0.01% |
220,780
+48,840
| +28% | +$1.87M |
|
440
Landstar System
LSTR
$6.11B
| $8.09M | 0.01% |
121,989
-4,272
| -3% | -$289K |
|
441
Walt Disney
DIS
$187B
| $8M | 0.01% |
76,283
-5,396
| -7% | -$544K |
|
|
YDKN
442
DELISTED
Yadkin Financial Corporation
YDKN
| $7.97M | 0.01% |
+392,428
| New | +$7.6M |
|
443
Petrobras Class A
PBR.A
$108B
| $7.92M | 0.01% |
1,300,000
+127,178
| +11% | +$827K |
|
|
PACD
444
DELISTED
Pacific Drilling S A
PACD
| $7.89M | 0.01% |
202,884
-198,581
| -49% | -$7.36M |
|
445
Dillards
DDS
$9.69B
| $7.87M | 0.01% |
57,663
+2,605
| +5% | +$325K |
|
446
Starwood Property Trust
STWD
$5.85B
| $7.86M | 0.01% |
323,490
+36,760
| +13% | +$884K |
|
447
iShares Russell 2000 Value ETF
IWN
$14.5B
| $7.77M | 0.01% |
75,300
-81,385
| -52% | -$8.21M |
|
|
ATSG
448
DELISTED
Air Transport Services Group
ATSG
| $7.77M | 0.01% |
842,700
+74,910
| +10% | +$654K |
|
|
NAVG
449
DELISTED
Navigators Group Inc
NAVG
| $7.76M | 0.01% |
199,424
-13,694
| -6% | -$511K |
|
450
TETRA Technologies
TTI
$1.01B
| $7.71M | 0.01% |
1,248,007
+515,353
| +70% | +$2.84M |
|
Similar funds
Boston Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Boston Partners held 780 positions worth $67.2B, up 0.81% from $66.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2015 filing shows 63 new, 245 increased, 379 reduced and 79 closed positions. Its largest new stake was Merck: 14,837,117 shares worth $814M. The largest sale was Citigroup, an estimated $489M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2015 buy was Merck: 14,837,117 shares worth $814M.
- Boston Partners added most to RTX Corp in Q1 2015, an estimated $638M increase.
- Boston Partners's biggest Q1 2015 reduction was Citigroup, cutting an estimated $489M.
- Boston Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $397M.
- Boston Partners's ten largest holdings make up 17% of its $67.2B portfolio in Q1 2015.
- Boston Partners opened 63 new positions and closed 79 in Q1 2015.
- Boston Partners's portfolio value rose 0.81% quarter-over-quarter to $67.2B.
Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.